Peptides and Protein Drug Delivery
Peptide and Protein drug conveyance framework are known as Novel Drug Delivery System. Proteins and peptides are the most plentiful parts of organic cells. They exist working like compounds, chemicals, primary component, and immunoglobulin. The twenty different normally unfold amino acids get together with one another by peptide bonds and develop polymers referenced to peptides and proteins. Albeit the difference among peptides and proteins are peptide having under 20 amino acids, having a sub-atomic weight under 5000, while a protein contain at least 50 amino acids and its sub-atomic weight lies high this worth. Numerous drug proteins and peptides are immersed IM, IV and Subcutaneous courses of Absorption, yet the oral course is more proper for retention of protein as gather to other people.
- Peptide and Protein drug conveyance
- Novel Drug Delivery System
- Immunoglobulin.
Related Conference of Peptides and Protein Drug Delivery
30th International Conference on Neuropharmacology and Neurochemistry
5th International Forum on Pharmacovigilance and Regulatory Affairs
Peptides and Protein Drug Delivery Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Anti-Cancer Drug Delivery Agents
- Cellular Targeting and Intracellular Delivery
- Drug Delivery Technologies
- Drug Delivery through Blood-Brain Barrier (BBB)
- Drug Discovery and Development
- Drug Targeting and Design
- Nanotechnology for better Drug Deliverability
- Novel Drug Delivery
- Peptides and Protein Drug Delivery
- Pharmaceutical Formulation Technologies
- Routes of Drug Administration
- Therapeutic Drug Carrier Systems
- Vaccine Drug Delivery Systems
Related Journals
Are you interested in
- Artificial Intelligence in Neuropharmacological Drug Discovery - Neuropharmaceutics 2027 (Netherlands)
- Blood-Brain Barrier Pharmacology and Drug Delivery - Neuropharmaceutics 2027 (Netherlands)
- Brain-Computer Interfaces and Neurochemical Modulation - Neuropharmaceutics 2027 (Netherlands)
- Computational and Systems Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Digital Biomarkers and Neurochemical Monitoring Technologies - Neuropharmaceutics 2027 (Netherlands)
- Integrating Neurochemistry with Computational Brain Modeling - Neuropharmaceutics 2027 (Netherlands)
- Machine Learning Models in Neurochemical Data Analysis - Neuropharmaceutics 2027 (Netherlands)
- Molecular Mechanisms in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Epilepsy and Anticonvulsant Pharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Basis of Mood Disorders and Emotional Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Big Data and Cloud-Based Pharmacology Platforms - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Biosensors and Real-Time Brain Monitoring - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Mechanisms in Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neurochemical Signaling and Synaptic Transmission - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Addiction and Reward Pathways - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Neuroendocrine Regulation - Neuropharmaceutics 2027 (Netherlands)
- Neurochemistry of Psychiatric and Mood Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuroimaging Analytics and Computational Mapping of Brain Chemistry - Neuropharmaceutics 2027 (Netherlands)
- Neuroinflammation and Pharmacological Modulation - Neuropharmaceutics 2027 (Netherlands)
- Neuroinformatics and Computational Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacological Approaches to Pain Modulation and Analgesia - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Addiction and Substance Abuse - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Cognitive Function and Memory - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodegenerative Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neurodevelopmental and Autism Spectrum Disorders - Neuropharmaceutics 2027 (Netherlands)
- Neuropharmacology of Neuroplasticity and Neural Regeneration - Neuropharmaceutics 2027 (Netherlands)
- Neurotransmitter Receptors and Signal Transduction - Neuropharmaceutics 2027 (Netherlands)
- Precision Neuropharmacology through Artificial Intelligence and Genomic Profiling - Neuropharmaceutics 2027 (Netherlands)
- Virtual Drug Screening and Molecular Docking in Neuropharmacology - Neuropharmaceutics 2027 (Netherlands)
